These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 27622968)
21. Clinical course of patients with idiopathic Parkinson's disease. Roos RA; Jongen JC; van der Velde EA Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138 [TBL] [Abstract][Full Text] [Related]
22. Understanding the Care Needs and Profile of People Living at Home With Moderate to Advanced Stage Parkinson Disease. Hand A; Oates LL; Gray WK; Walker RW J Geriatr Psychiatry Neurol; 2018 Sep; 31(5):237-247. PubMed ID: 30012028 [TBL] [Abstract][Full Text] [Related]
23. Nonmotor symptoms in nursing home residents with Parkinson's disease: prevalence and effect on quality of life. Weerkamp NJ; Tissingh G; Poels PJ; Zuidema SU; Munneke M; Koopmans RT; Bloem BR J Am Geriatr Soc; 2013 Oct; 61(10):1714-21. PubMed ID: 24117286 [TBL] [Abstract][Full Text] [Related]
24. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital. Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818 [TBL] [Abstract][Full Text] [Related]
25. Management of postural sensory conflict and dynamic balance control in late-stage Parkinson's disease. Colnat-Coulbois S; Gauchard GC; Maillard L; Barroche G; Vespignani H; Auque J; Perrin PP Neuroscience; 2011 Oct; 193():363-9. PubMed ID: 21627979 [TBL] [Abstract][Full Text] [Related]
26. Frequency and clinical correlates of retrocollis in Parkinson's disease. Kashihara K; Imamura T J Neurol Sci; 2013 Jan; 324(1-2):106-8. PubMed ID: 23151424 [TBL] [Abstract][Full Text] [Related]
27. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients. Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890 [TBL] [Abstract][Full Text] [Related]
28. Effects of disease severity and medication state on postural control asymmetry during challenging postural tasks in individuals with Parkinson's disease. Barbieri FA; Polastri PF; Baptista AM; Lirani-Silva E; Simieli L; Orcioli-Silva D; Beretta VS; Gobbi LT Hum Mov Sci; 2016 Apr; 46():96-103. PubMed ID: 26741255 [TBL] [Abstract][Full Text] [Related]
29. Maintaining balance against force perturbations: impaired mechanisms unresponsive to levodopa in Parkinson's disease. Di Giulio I; St George RJ; Kalliolia E; Peters AL; Limousin P; Day BL J Neurophysiol; 2016 Aug; 116(2):493-502. PubMed ID: 27098030 [TBL] [Abstract][Full Text] [Related]
31. [Treatment for advanced Parkinson's disease with intestinal levodopa/carbidopa gel: review of efficacy and safety]. Timofeeva AA Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):145-51. PubMed ID: 25629138 [TBL] [Abstract][Full Text] [Related]
32. Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings. Chenoweth L; Sheriff J; McAnally L; Tait F Nurse Educ Today; 2013 May; 33(5):458-64. PubMed ID: 22626862 [TBL] [Abstract][Full Text] [Related]
33. The effect of Parkinson's disease and levodopa on adaptation of anticipatory postural adjustments. Hall LM; Brauer SG; Horak F; Hodges PW Neuroscience; 2013 Oct; 250():483-92. PubMed ID: 23867768 [TBL] [Abstract][Full Text] [Related]
34. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study. Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722 [TBL] [Abstract][Full Text] [Related]
35. Management of levodopa for residents with Parkinson's disease. Mages L Nurs Older People; 2016 Oct; 28(9):23-30. PubMed ID: 27788653 [TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease. Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409 [TBL] [Abstract][Full Text] [Related]
38. Small (autonomic) and large fiber neuropathy in Parkinson disease and parkinsonism. de Araújo DF; de Melo Neto AP; Oliveira ÍS; Brito BS; de Araújo IT; Barros IS; Lima JW; Horta WG; Gondim Fde A BMC Neurol; 2016 Aug; 16():139. PubMed ID: 27530902 [TBL] [Abstract][Full Text] [Related]
39. PPNa-DBS for gait and balance disorders in Parkinson's disease: a double-blind, randomised study. Welter ML; Demain A; Ewenczyk C; Czernecki V; Lau B; El Helou A; Belaid H; Yelnik J; François C; Bardinet E; Karachi C; Grabli D J Neurol; 2015 Jun; 262(6):1515-25. PubMed ID: 25904205 [TBL] [Abstract][Full Text] [Related]
40. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa]. Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]